Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 13, 2007. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on April 12, 2007. Each individual acquired 9 shares through the personal contribution element and 9 shares through the matching element of the Company's ShareReward Plan. The purchase price was GBP 14.12 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share purchases described above.
Key Facts for Investor Verification
- Transaction Date: April 12, 2007.
- Share Price: GBP 14.12 per Ordinary Share.
- Participants: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty.
- Volume per Participant: 18 shares total (9 personal, 9 company match).
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.